BioSpace News Archive

ERYTECH Pharma announced that it will present preclinical data on the enzymatic activity of eryaspase (GRASPA®) at the European Hematology Association (EHA) Congress

Arrayit Corporation announces that the company has engaged a nationwide network of professional sales representatives to sell and distribute the company’s allergy tests across the Continental United States, with focus areas in the Pacific Northwest, West, Southwest, Rocky Mountain, Midwest, Northeast and Southeast regions.

Crown Bioscience announces that it has been selected by Pierre Fabre Research Institute as one of their partners to advance their immuno-oncology drug discovery pipeline.

Provectus today announced that the Indian Patent Office (IPO) has granted the Company’s patent application for the synthetic process used to produce the active pharmaceutical ingredient (API) in PV-10, which is Provectus’ lead investigational oncology drug.

LogistiCare announced Richard Boland, Jr. has joined the company as chief operating officer.

OptimizeRx Corp. has uplisted to the Nasdaq Capital Market, with its common stock to commence trading on the exchange beginning Friday, June 22, 2018 under the symbol, “OPRX.”

Cryo-Cell International, Inc. announced that it has completed its acquisition of substantially all of the assets of CORD:USE Cord Blood Bank, Inc.

Nuvus Gro Corp. introduces the pinnacle of modular constructed all-in-one cultivation and processing facilities.

Therapeutics Solutions International, Inc. announced their plans to provide access to its clinical stage cancer immunotherapy product StemVacs under the Right To Try law signed by President Trump on May 30th 2018, and have appointed Dr. James Veltmeyer as Chief Medical Officer of their future planned cancer clinic.

Study results presented from 46 patients treated over two years with zero complications